An Observational Study on the Use of Glucophage XR® Therapy in the Management of Patients With Type 2 Diabetes

Trial Profile

An Observational Study on the Use of Glucophage XR® Therapy in the Management of Patients With Type 2 Diabetes

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 29 Jul 2014

At a glance

  • Drugs Metformin (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Adverse reactions
  • Sponsors Merck KGaA
  • Most Recent Events

    • 18 Jun 2014 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 04 Oct 2012 Planned end date changed from 1 Jun 2012 to 1 Feb 2013 as reported by ClinicalTrials.gov.
    • 20 Jun 2011 Actual initiation date (Jun 2011) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top